Chang Xu

2007.09–2015.07, 2004.09–2007.08 2015.08–2016.09 2016.10–2018.07 2018.08–2025.07 2025.08– 1. 2. 3. (ISAPS) (WPATH) “ ” 2025 [1] Zhang C, Chang X, Chen L, et al. Safety and Efficacy of Micronized Acellular Dermal Matrix Injection for Correction of Moderate to Severe Nasolabial Folds: A Double-Blind, Multicenter, Randomized Controlled, Non-inferior Clinical Trial. Aesthetic Plast Surg. 2025. [2] Wang G, Chang X, Yang X, et al. Surgical Experience and Outcome Evaluation of Genital Gender Affirmation Surgery for Transgender Female in China: A Case Series. Aesthetic Plast Surg. 2025. 49(10): 2850-2859. [3] Yang W, Hong T, Chang X, et al. The efficacy of and user satisfaction with different antiandrogens in Chinese transgender women. Int J Transgend Health. 2024. 25(3): 471-482. [4] Wang Q, Yang X, Ma J, et al. PI3K/AKT pathway promotes keloid fibroblasts proliferation by enhancing glycolysis under hypoxia. Wound Repair Regen. 2023. 31(2): 139-155. [5] Ma JX, Li B, Xia YC, et al. Latissimus dorsi muscle flap transfer through endoscopic approach combined with the implant after tissue expansion for breast reconstruction of mastectomy patients. BMC Surg. 2022. 22(1): 10. [6] Ma JX, Xia YC, Zou LP, et al. Sirolimus as a promising drug therapy for blue rubber bleb nevus syndrome: Two-case report. SAGE Open Med Case Rep. 2022. 10: 2050313X221097755. [7] Liu Y, Xin Y, Qi J, et al. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study. J Sex Med. 2020. 17(11): 2291-2298. [8] *,, #..,2018,34(7):574-577. [9] *,, #,. HaiMed.,2021,37(1):35-39. 《 》、《 》, 《Gender Confirmation Surgery》《Topics in Head and Neck Reconstruction》《Plastic & Reconstructive Surgery Board Review》,.